1. Home
  2. VIR vs ATEN Comparison

VIR vs ATEN Comparison

Compare VIR & ATEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ATEN
  • Stock Information
  • Founded
  • VIR 2016
  • ATEN 2004
  • Country
  • VIR United States
  • ATEN United States
  • Employees
  • VIR N/A
  • ATEN N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ATEN EDP Services
  • Sector
  • VIR Health Care
  • ATEN Technology
  • Exchange
  • VIR Nasdaq
  • ATEN Nasdaq
  • Market Cap
  • VIR 1.4B
  • ATEN 1.5B
  • IPO Year
  • VIR 2019
  • ATEN 2014
  • Fundamental
  • Price
  • VIR $7.00
  • ATEN $16.38
  • Analyst Decision
  • VIR Buy
  • ATEN Buy
  • Analyst Count
  • VIR 6
  • ATEN 2
  • Target Price
  • VIR $35.67
  • ATEN $21.00
  • AVG Volume (30 Days)
  • VIR 1.1M
  • ATEN 1.2M
  • Earning Date
  • VIR 05-01-2025
  • ATEN 04-29-2025
  • Dividend Yield
  • VIR N/A
  • ATEN 1.47%
  • EPS Growth
  • VIR N/A
  • ATEN 26.42
  • EPS
  • VIR N/A
  • ATEN 0.67
  • Revenue
  • VIR $74,205,000.00
  • ATEN $261,696,000.00
  • Revenue This Year
  • VIR N/A
  • ATEN $9.39
  • Revenue Next Year
  • VIR $17.69
  • ATEN $7.96
  • P/E Ratio
  • VIR N/A
  • ATEN $24.44
  • Revenue Growth
  • VIR N/A
  • ATEN 3.97
  • 52 Week Low
  • VIR $6.56
  • ATEN $12.27
  • 52 Week High
  • VIR $14.45
  • ATEN $21.90
  • Technical
  • Relative Strength Index (RSI)
  • VIR 28.28
  • ATEN 22.38
  • Support Level
  • VIR $6.96
  • ATEN $19.08
  • Resistance Level
  • VIR $7.46
  • ATEN $19.91
  • Average True Range (ATR)
  • VIR 0.57
  • ATEN 0.71
  • MACD
  • VIR -0.16
  • ATEN -0.38
  • Stochastic Oscillator
  • VIR 1.56
  • ATEN 7.12

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

Share on Social Networks: